IGF2BP3 and hepatocellular carcinoma: Subsequent in vitro and in vivo experiments were conducted to explore the modulation of LL22NC03 expression, in combination with manipulation of IGF2BP3 levels, which significantly impacted glycolysis, proliferation, migration, and invasiveness of HCC cells.<h4>Results</h4>The study identified LL22NC03 as a promoter of HCC proliferation and migration of HCC cells.